Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS · Delayed Price · Currency is USD
22.68
+0.74 (3.37%)
At close: Sep 22, 2025
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of $4.82 billion as of September 22, 2025. Its market cap has decreased by -14.45% in one year.
Market Cap
4.82B
Enterprise Value
6.13B
Revenue
3.22B
Ranking
n/a
PE Ratio
12.99
Stock Price
$22.68
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 4.82B, an increase of 478.06%. That is a compound annual growth rate of 9.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 4.82B | -12.88% |
| Dec 31, 2024 | 5.53B | 9.82% |
| Dec 29, 2023 | 5.04B | 22.33% |
| Dec 30, 2022 | 4.12B | -40.78% |
| Dec 31, 2021 | 6.95B | -12.23% |
| Dec 31, 2020 | 7.92B | 24.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 791.41M |
| Tian'an Technology Group | 728.29M |
| Elite Pharmaceuticals | 668.08M |
| Glass House Brands | 538.12M |
| Northwest Biotherapeutics | 376.65M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 351.92M |
| American Oncology Network | 347.09M |